Peripheral blood examination to assess bleeding risk in children with dengue infections

  • Irene Huwae Department of Child Health, Brawijaya University Medical School/Dr. Saiful Anwar General Hospital, Malang
  • Kurniawan Kadafi Department of Child Health, Brawijaya University Medical School/Dr. Saiful Anwar General Hospital, Malang
Keywords: peripheral blood, dengue virus, bleeding

Abstract

Background Dengue viral infection may cause mild to severe
clinical manifestations, with or without bleeding. A number of
factors may cause bleeding in patients with dengue. However,
health providers may be unable to perform the examinations
required to sufficiently predict the risk of bleeding.
Objective To find risk factors for bleeding using peripheral blood
examinations in children with dengue infection.
Methods This crossô€sectional study was conducted at the
Pediatric Ward of the Dr. Saiful Anwar General Hospital,
Malang, from January 2010 to December 2011. We included
children aged 1 to 18 years with dengue viral infection, as
confirmed by the 1997 WHO criteria and serology. Peripheral
blood examinations were made daily, depending on the patient's
condition. We classified the bleeding status into nonô€bleeding,
petechial bleeding (mild hemorrhage), and mucosal bleeding
(severe hemorrhage). We recorded subjects' bleeding status at
the time of their highest packed cell volume (PCV), and recorded
their leukocyte and platelet counts at that time. We computed
the parameters' medians and compared them to bleeding status
by Chiô€square test. For significant (P<0.05) associations we
calculated the OR (odds ratio) \\lith a 95% confidence interval.
All patients were treated according to the 1997 WHO dengue
guidelines.
Results There were all 294 subjects with dengue and 282
subjects had complete data, 202 \\lith bleeding (120 petechial,
82 mucosal bleeding) and 80 without bleeding. The median
PCV was 36.8%, while median platelet count was 51,000/,uL
and median leukocyte count was 3,400/,uL. The OR of PCV
> 36.8% for bleeding was 2.31 (95%CI 1.35 to 3.95). The OR
of platelet count <51,000/ ,uL for bleeding was 2.34 (95%CI
1.37 to 3.99) compared to platelet count> 51,000/ ,uL. The
OR of platelet count < 51,000/ ,uL for mucosal bleeding was
3.39 (95%CI 1.78 to 6.48). Chiô€square analysis for leukocyte
count showed it was not associated with bleeding in dengue
(Pô€‘ 0.186).

Conclusion The PCV level > 36.8% increased the risk for
bleeding by 2.31 times, for both petechial and mucosal bleeding.
Platelet count < 51,000/ ,uL increased the risk for bleeding 2.34
times and for mucosal bleeding by 3.4 times. Leukocytes count
was not associated with bleeding. Basic laboratory examinations
of PCV and platelet count may, therefore, be used as a predictor
of bleeding in children with dengue infection. [paediatr lndones.
2012;52:175-80].

References

1. Khrisnamurti C, Kalayanarooj S, Cutting MA, Peat RA,
Rothwell SW, Reid TJ, etal. Mechanisms of hemorrhage
in dengue without circulatory collapse. Am J Trop Med.
2001;65,840-7.
2. UKK Infeksi dan Pediatri Tropis. Infeksi virus dengue. In:
Soedarmo SSp, Gama H, Hadinegoro SR, Satari HI, editors.
Buku ajar infeksi dan pediatri tropis. 2nd ed. Jakarta: Badan
Penerbit IDAI; 2008. p. 155-81.
3. Carlos CC, Oishi K, Cinco MTDD, Mapua CA, Inoue S, Cruz
DJ M, et al. Comparison of clinical features and hematologic
abnormalities between dengue fever and dengue hemorrhar􀁝
gic fever among children in the P hilippines. Am J Trop Med
Hyg. 2005;73;435-40.
4. Shu PY, Huang JH. Current advances in dengue diagnosis.
Clin Diagn Lab Immuno!. 2004;1 [;642-50.
5. Martina BEE, Koraka P, Osterhaus ADME. Dengue virus
pathogenesis: an integrated view. Clin Microbiol Rev.
2009;22,564-81.
6. World Health Organization. Dengue: guidelines for diagnosis,
treatment, prevention, and control. 2009.
7. Balmaseda A, Hammond SN, Perez MA, Cuadra R, Solano S,
Rocha J, et al. Short report: assessment of the World Health
Organization scheme for classification of dengue severity in
Nicaragua. Am) Trop Hyg. 2005;73,1059-62.
8. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio
SI, Mercado JC. Differences in dengue severity in infants,
children, and adults in a 3􀁝year hospital􀁝based study in
Nicaragua. Am) Trop Med Hyg. 2005;73;1063-70.
9. Gibbons RV, Vaughn DW Dengue: an escalating problem.
BM).2002 ;324, 1563-6.
10. P huong CXT, Nhan NT, Kneen R, T huy PT, T hien Cv, Nga
NIT, et al. Clinical diagnosis and assessment of severity of
confirmed dengue infections in Vietnamese children: is the
World Health Organization classification system helpful?
Am) Trop Med Hyg. 2004;70,172-9.
11. Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS,
Souza AL, et al. Essential role of platelet􀁝activating factor
receptor in the pathogenesis of dengue virus infection. P NAS.
2009; 106, 14138-13.
12. Assuncao􀁝Miranda I, Amaral FA, Bozza FA, Fagundes cr,
Sousa LP, Souza DG, et al. Contribution of macrophage
migration inhibitory factor to the pathogenesis of dengue
virus infection. FASEB). 2010;24,218-28.
13. Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK,
et al. Molecular mimicry between virus and host and its
implications for dengue disease pathogenesis. Exp Biol Med.
2011;236,515-23.
14. Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, Yeh TM, et
al. Deletion of the C􀁝terminal region of dengue virus
nonstructural protein 1 (NS 1) abolishes anti􀁝NSl􀁝mediated
platelet dysfunction and bleeding tendency. J Immunol.
2009; 183,1797-803.
15. Wills B, Ngoc TV, Van NTH, T huy T TI, T huy TIN,
DungNM, et al. Hemostatic changes in Vietnamese children
Mth mild dengue correlate Mth the severity of vascular leakage
rather than bleeding. Am) Trop Med Hyg. 2009;8[;638-44.
16. Duyen HT L, Ngoc TV, Ha do T, Hang VTT, Kieu NIT,
Young PR, et al. Kinetics of plasma viremia and soluble
nonstruct ural protein 1 concentrations in dengue: differential
effects according to serotype and immune status. J Infect Dis.
2011 ;203 ,1292-300.
17. K rishnamurti C, Peat RA, Cutting MA, Rot hwell SW.
Platelet adhesion to dengue􀁓2 virus􀁓infected endot helial
cells. Am J Trop Med Hyg.2002;66A35-41.
18. De Rivera IL, Parham L, Murillo W, Moncada W, Vazquez
S. Humoral immune response of dengue hemorrhagic fever
cases in children from Tegudpalga, Honduras. Am J Trop
Med Hyg. 2008;79,262-6.
19. Gregory CJ, Santiago LM, Arguello DF, Hunsperger E,
Tomashek K M. Clinical and laboratory features that
differentiate dengue from other febrile illnesses in an
endemic area - Puerto Rico, 2007􀁓2008. Am J Trop Hyg.
2010;82,922-9.
20. Kittigul L, Pitakamjanakul p, Sujiarat D, Siripanichgon K .
T h e differences of clinical manifestations and laboratory
findings in children and adults 'With dengue virus infection.
J Clin Viro!. 2007 ;39,79-81.
21. Gupta V, YadafTp, Pandey RM, Singh A, Gupta M, Kanaujiya
P, et al. Risk factors of dengue shock syndrome in children.
J Trop Pediatr. 2011;57A51-6.
Published
2012-06-30
How to Cite
1.
Huwae I, Kadafi K. Peripheral blood examination to assess bleeding risk in children with dengue infections. PI [Internet]. 30Jun.2012 [cited 22Nov.2024];52(3):175-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/387
Section
Articles
Received 2016-08-30
Accepted 2016-08-30
Published 2012-06-30